Baseline characteristics
| Characteristic . | Patients (n = 116) . | |
|---|---|---|
| Mean age, y | 6.70 ± 3.71 | 0.58-16 |
| Female sex | 46 | 39.7 |
| Mean weight, kg | 28.14 ± 14.84 | 7-73 |
| Mean baseline platelet count × 109/L | 10.16 ± 7.07 | 1-29 |
| Mean ITP duration, y | 2.91 ± 2.62 | 0.08-11 |
| ITP phase | ||
| Chronic | 102 | 87.9 |
| Persistent | 14 | 12.1 |
| Concomitant ITP medication use | 43 | 37.1 |
| No. of previous ITP treatments | ||
| 1 | 7 | 6.0 |
| 2 | 25 | 21.6 |
| ≥3 | 84 | 72.4 |
| Characteristic . | Patients (n = 116) . | |
|---|---|---|
| Mean age, y | 6.70 ± 3.71 | 0.58-16 |
| Female sex | 46 | 39.7 |
| Mean weight, kg | 28.14 ± 14.84 | 7-73 |
| Mean baseline platelet count × 109/L | 10.16 ± 7.07 | 1-29 |
| Mean ITP duration, y | 2.91 ± 2.62 | 0.08-11 |
| ITP phase | ||
| Chronic | 102 | 87.9 |
| Persistent | 14 | 12.1 |
| Concomitant ITP medication use | 43 | 37.1 |
| No. of previous ITP treatments | ||
| 1 | 7 | 6.0 |
| 2 | 25 | 21.6 |
| ≥3 | 84 | 72.4 |
Data are n (%) or mean ± standard deviation.